SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-463425
Filing Date
2012-11-09
Accepted
2012-11-09 16:31:49
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d413091d10q.htm 10-Q 517906
2 EX-31.1 d413091dex311.htm EX-31.1 10097
3 EX-31.2 d413091dex312.htm EX-31.2 10427
4 EX-32.1 d413091dex321.htm EX-32.1 5439
  Complete submission text file 0001193125-12-463425.txt   4424114

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aria-20120930.xml EX-101.INS 571596
6 XBRL TAXONOMY EXTENSION SCHEMA aria-20120930.xsd EX-101.SCH 47582
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aria-20120930_cal.xml EX-101.CAL 69091
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aria-20120930_def.xml EX-101.DEF 264148
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aria-20120930_lab.xml EX-101.LAB 370590
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aria-20120930_pre.xml EX-101.PRE 314518
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 121194079
SIC: 2836 Biological Products, (No Diagnostic Substances)